{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-096743","form_type":"8-K","ticker":"AIDX","cik":"0001139685","company_name":"20/20 Biolabs, Inc.","filed_at":"2026-09-02T20:32:39+00:00","discovered_at":"2026-09-02T20:34:01.434720+00:00","generated_at":"2026-09-02T20:34:13.537710+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"20/20 Biolabs furnishes Sept 2026 investor presentation; no financial detail disclosed","bullets":["20/20 Biolabs (AIDX) furnished an investor presentation, dated September 2026, for use in a Sept 2, 2026 investor webinar.","Presentation text included in the exhibit contains only a cover slide; no revenue, EPS, pipeline, or guidance figures were provided.","CEO Jonathan Cohen signed the 8-K; no operational or financial updates were disclosed in the filing body or exhibit.","Material news content could not be extracted from the available exhibit text."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-096743","json":"https://secwatch.observer/filing/0001213900-26-096743.json","markdown":"https://secwatch.observer/filing/0001213900-26-096743.md","text":"https://secwatch.observer/filing/0001213900-26-096743.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026096743/0001213900-26-096743-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026096743/ea0304455-8k_2020bio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T20:34:13.537710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}